Tilray Brands (TLRY) EBT Margin (2017 - 2026)

Tilray Brands (TLRY) posted EBT Margin of 11.25% for Q1 2026, up 38.77% on a QoQ basis from 18.37% in Q4 2025, and up 41524.0% year-over-year from N/an in Q1 2025.

Tilray Brands (TLRY) EBT Margin (2017 - 2026) Analysis & Trends

Tilray Brands' EBT Margin history runs 10 years deep, the most recent figure standing at 11.25% for Q1 2026.

  • Quarterly EBT Margin rose 41524.0% year-over-year to 11.25% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 169.76% (down 6935.0% YoY) and the FY2025 annual result came in at 280.33%, down 26427.0% from the prior year.
  • EBT Margin was 11.25% for Q1 2026 at Tilray Brands, up from 18.37% in the prior quarter.
  • Across five years, EBT Margin topped out at 451.45% in Q2 2023 and bottomed at 828.75% in Q1 2023.
  • A 5-year average of 106.36% and a median of 27.46% in 2023 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2023 — EBT Margin slumped 86209 bps — and 2024, when it surged 77148 bps.
  • Tilray Brands' EBT Margin stood at 50.89% in 2022, then surged by 50 bps to 25.58% in 2023, then tumbled by 54 bps to 39.46% in 2024, then soared by 53 bps to 18.37% in 2025, then jumped by 39 bps to 11.25% in 2026.
  • Business Quant data shows TLRY's EBT Margin at 11.25% in Q1 2026, 18.37% in Q4 2025, and 0.37% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn -11.25%

Historic Data

Download Data
DateValue
Feb 28, 2026 -11.25%
Nov 30, 2025 -18.37%
Aug 31, 2025 -0.37%
May 31, 2025 -620.41%
Feb 28, 2025 -426.49%
Nov 30, 2024 -39.46%
Aug 31, 2024 -16.88%
May 31, 2024 34.49%
Feb 29, 2024 -57.27%
Nov 30, 2023 -25.58%
Aug 31, 2023 -27.46%
May 31, 2023 451.45%
Feb 28, 2023 -828.75%
Nov 30, 2022 -50.89%
Aug 31, 2022 -38.24%
May 31, 2022 -166.07%
Feb 28, 2022 33.35%
Nov 30, 2021 0.08%
Aug 31, 2021 -17.76%
May 31, 2021 264.02%